Tuning morphology in active pharmaceutical ingredients: controlling the crystal habit of lovastatin through solvent choice and non-size-matched polymer additives

Additive crystallization routes to control the crystal habit of the active pharmaceutical ingredient (API) lovastatin are presented, at small scale up to 25 mL. Lovastatin is an archetypical example of an API that forms needle-like crystals via solution-based recrystallization, causing issues for do...

Full description

Saved in:
Bibliographic Details
Main Authors: Lauren E Hatcher, Wei Li, Pollyanna Payne, Brahim Benyahia, Chris Rielly, Chick C Wilson
Format: Default Article
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/2134/12977585.v1
Tags: Add Tag
No Tags, Be the first to tag this record!